日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor on Resistance to a CDK4/6 Inhibitor and Endocrine Therapy in ER(+)/HER2(-) Breast Cancer Preclinical Models

口服FGFR1-3抑制剂Tasurgratinib对ER(+)/HER2(-)乳腺癌临床前模型中CDK4/6抑制剂和内分泌治疗耐药性的影响

Kawano, Satoshi; Fukushima, Sayo; Nishibata, Kyoko; Gejima, Ryu; Miyano, Saori Watanabe

Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease

新型自噬诱导剂通过加速溶酶体聚集来对抗帕金森病

Yuki Date, Yukiko Sasazawa, Mitsuhiro Kitagawa, Kentaro Gejima, Ayami Suzuki, Hideyuki Saya, Yasuyuki Kida, Masaya Imoto, Eisuke Itakura, Nobutaka Hattori, Shinji Saiki

A case of gallbladder neuroendocrine carcinoma diagnosed preoperatively using somatostatin receptor scintigraphy

一例术前通过生长抑素受体闪烁显像诊断的胆囊神经内分泌癌病例

Kamikihara, Yusuke; Tanoue, Shiroh; Kawahira, Machiko; Iwaya, Hiromichi; Arima, Shiho; Sasaki, Fumisato; Nasu, Yuichiro; Hashimoto, Shinichi; Kanmura, Shuji; Higashi, Michiyo; Gejima, Kentaro; Ido, Akio

Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study.

血小板内 VWF 的二价特性在肝脏再生和 HCC 复发中的作用:一项前瞻性多中心研究。

Aryal Bibek, Yamakuchi Munekazu, Shimizu Toshiaki, Kadono Jun, Furoi Akira, Gejima Kentaro, Takenouchi Kazunori, Komokata Teruo, Hashiguchi Teruto, Imoto Yutaka

Predictive Value of Diminished Serum PDGF-BB after Curative Resection of Hepatocellular Cancer

肝细胞癌根治性切除术后血清PDGF-BB水平降低的预测价值

Aryal, Bibek; Yamakuchi, Munekazu; Shimizu, Toshiaki; Kadono, Jun; Furoi, Akira; Gejima, Kentaro; Komokata, Teruo; Koriyama, Chihaya; Hashiguchi, Teruto; Imoto, Yutaka

Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma

解读血小板动力学在肝细胞癌诊断和预后评估中的应用

Aryal, Bibek; Yamakuchi, Munekazu; Shimizu, Toshiaki; Kadono, Jun; Furoi, Akira; Gejima, Kentaro; Komokata, Teruo; Hashiguchi, Teruto; Imoto, Yutaka